Italian study backs Matritech's bladder cancer test:
This article was originally published in Clinica
Matritech's NMP22 urine test for bladder cancer is better at detecting the disease than traditional urine cytology or the bladder tumour antigen (BTA) test, according to an Italian study. Researchers at the Institute of Urology in Milan compared the three tests in 105 bladder cancer patients. They found that NMP22 levels showed a sensitivity of 92% for transitional cell carcinoma of the bladder compared with 46.6% for urinary cytology and 50.6% for the BTA test which is made by Polymedco of Cortlandt Manor, New York. The study is published in the February issue of European Urology.
You may also be interested in...
According to the plaintiff, Unilever’s Pond’s Rejuveness Anti-Wrinkle Cream is defective insofar as tested product has been found to contain unlabeled mercury, constituting negligence that has resulted in user injuries. The plaintiff seeks certification of a transnational class and compensatory and punitive damages, among other relief.
HBW Product Launches: New Chapter Collagen, Alkamind Acid-Kicking, GNC China, Tetra Bio Canada, More
GNC, Harbin launch supplements in China following regulatory approval; Bee Gone expands with allergy swabs; Bed, Bath & Beyond expands distribution of CBDMedic personal care products promoted by Rob Gronkowski; Tetra Bio has Canadian OK For hemorrhoid and pain relief OTCs, US and European pending; Agrozen offers Urban Daze CBD products; New Chapter portfolio expansion also includes fermented vitamins, elderberry supplements and magnesium; and Alkamind’s Acid-Kicking Coffee Alkalizer creamers help neutralize acid from coffee.
In joint complaint, the FTC and New York Attorney General allege scheme to block generic Daraprim and maintain exorbitant list price; they cite hundreds of emails the incarcerated Shkreli has exchanged with co-defendant in last six months.